Gothenburg, Sweden, October 21-25, 2019

Citation: Klar F “2019 Universe of Pre-filled Syringes & Injection Devices Preview”. ONdrugDelivery Magazine, Issue 100 (Sep 2019), pp 42.

By Falk Klar, PhD, General Manager, PDA Europe

PDA Europe is proud to present the 16th edition of its signature event The Universe of Pre-filled Syringes and Injection Devices – a must-attend conference for everyone working in the fields of parenteral drugs and device development, covering solutions to challenges regarding new developments, regulatory considerations, and industry trends.

The conference started in 2004 as a small local event, with a sole focus on prefilled syringes, which attracted about 100 attendees. Back then it was the first event of its kind to offer a platform for high-level exchange on the topic. A few years later, injection devices were added to the conference title, reflecting the expanding role of the prefilled syringe as the container of choice for this rapidly evolving market segment. After growing consistently over the years, PDA Europe is proud that in 2019 we are expecting >1,000 delegates and >100 exhibitors.

Once again, a special focus is set on the patient, as reflected in its motto: Advancing Drug Delivery Systems to improve Patients’ Lives.

The patient perspective is also provided directly by a patient speaker, as has become a PDA tradition at this event. With all the innovations around connected health the patient will address what it actually means to be a patient in the digital age.

Speakers from the pharma industry and the payer side will discuss the growing number of drugs that are delivered in a home setting followed by a panel discussion. Fresh perspectives will be exchanged on how all stakeholders can operate and benefit from innovations in drug delivery systems.

As is customary, industry speakers will discuss technology news and highlights as well as providing regulatory highlights. Digital health keeps evolving as a hot industry topic and hence many speakers will also review this in the industry context.

The Bill & Melinda Gates Foundation will present on the unique challenges they face to bring injectable therapies to the developing world. Besides the plenary keynote speakers, there will be multiple parallel tracks with presentations across the board. Speakers will discuss topics including large-volume injection, human factors in engineering, connectivity and devices, novel therapeutics, manufacturing & processing technologies, and more – and of course there will be regulatory perspectives.


A series of multiple satellite events around the two-day conference offers attendees the chance to learn about container closure integrity testing, test methods for prefilled syringes, extractables & leachables, and innovative drug delivery systems and combination products.

A large industry exhibition will take place during the main conference. Here delegates will have the opportunity to look at innovations and recent developments around drug delivery systems. Furthermore, they can interact and network with industry peers.

For more information and to register, visit www.pda.org/EU/UPS2019. If you have questions or need more information, please contact PDA Europe.

T: +49 30 436 55 08-10
E: [email protected]